On the heels of $225M roy­al­ty deal, Ko­di­ak shoots for $250M raise to fund piv­otal pro­grams of its Eylea slay­er

Bak­er Bros. didn’t have to wait long for Ko­di­ak Sci­ences’ next stock raise, for which they pledged to in­vest $25 mil­lion. Just a day af­ter nail­ing $225 mil­lion from a sale of fu­ture roy­al­ties to the in­vest­ment firm, Ko­di­ak is of­fer­ing $250 mil­lion worth of shares $KOD on the pub­lic mar­ket.

De­spite a slight drop pre-mar­ket, Ko­di­ak’s cur­rent stock price, at $47, is still up 34% com­pared to Mon­day morn­ing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER